PATENT CLAIM ANALYSIS

Application Number: 16329154
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "444000"]

Abstract:
The present invention provides an agent or pharmaceutical composition for eliminating senescent cells, comprising an SGLT2 inhibitor.

Claim (Index 13):
A method for preventing or treating a disease in which the disease state is expected to be improved by eliminating senescent cells, comprising administrating an effective amount of an SGLT2 inhibitor to a subject in need thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15565317', '15455684', '15956613', '15827539', '16007880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.736453737692439
- 35 USC 102 Novelty (BERT): 0.4966414617921665
- Combined Prediction Score: 0.7124725101024119
- Mean Citation Score: 225.980686
- Max Citation Score: 238.07213
- Similarity Product: 172.42724956041454

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test